WEI CHEN, MD, PHD
Medical Practice in Columbus, OH

License number
Ohio 57.019473
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
License number
Ohio 35120386
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
Address
Address
410 Doan Hall, Columbus, OH 43210
Phone
(614) 293-2458

Professional information

Wei Chen Photo 1

Wei Chen

Work:
Waste Management
GIS Analyst
The Ohio State University - Columbus, OH
Research Assistant for NASA MARS Project
The Ohio State University
Teaching Assistant for Professor Ron Li
Shanghai Municipal Engineering Design Institute
Transportation Planner
Shenzhen Beilinyuan Architecture & Landscape Design LTD - Shenzhen, CN
GIS Analyst
Education:
UH
Certificate in Project Management
The Ohio State University - Columbus, OH
M.S.
Kyushu University
Transportation Planning
Wuhan University - Wuhan, CN
MS in Urban Planning
Wuhan Technical University of Surveying and Mapping - Wuhan, CN
BE in Urban Planning


Wei Chen Photo 2

Dr. Wei Chen, Columbus OH - MD (Doctor of Medicine)

Specialties:
Anatomic & Clinical Pathology
Address:
410 W 10Th Ave, Columbus 43210
(614) 293-2458 (Phone)
Languages:
English
Hospitals:
410 W 10Th Ave, Columbus 43210
Wexner Medical Center at The Ohio State University
410 West 10Th Ave, Columbus 43210


Wei Chen Photo 3

Dr. Wei Chen, Columbus OH - MD (Doctor of Medicine)

Specialties:
Anatomic & Clinical Pathology, Pathology
Age:
42
Address:
410 W 10Th Ave, Columbus 43210
(614) 293-2458 (Phone)
Languages:
English


Wei Chen Photo 4

Wei Chen, Columbus OH

Specialties:
Pathologist
Address:
410 W 10Th Ave, Columbus, OH 43210


Wei Chen Photo 5

Curcumin Compositions And Uses Thereof

US Patent:
2013014, Jun 6, 2013
Filed:
Aug 17, 2011
Appl. No.:
13/817260
Inventors:
Zhongfa Liu - Columbus OH, US
Ming Heung Chiu - Columbus OH, US
Wei Chen - Columbus OH, US
Assignee:
THE OHIO STATE UNIVERSITY - Columbus OH
International Classification:
A61K 31/12
US Classification:
514679
Abstract:
A composition and method of increasing the bioavailability of curcumin is provided. A synergistic combination of excipient polymers provides increased bioavailability thereby increasing the plasma concentration of curcumin and its metabolite curcumin O-glucuronide. The curcumin pharmaceutical compositions are suitable for modifying DNA methylation and treating diseases such as cancer.